Abstract:Key PointsResveratrol, a small polyphenol, has been discovered and re-discovered as a potential therapeutic in recent years. Although putative cardioprotective effects were first noted in 1982, it was only after a 1992 report of high levels of resveratrol in red wine that these effects were investigated extensively. In 1997, resveratrol was isolated in a screen for cyclooxygenase inhibitors, and was shown to be an effective chemotherapeutic and chemopreventive agent. Moreover, in 2003, it was identified as the top hit in a screen for activators of sirtuin deacetylases and was shown to extend the lifespans of lower organisms.The number of reported effects for resveratrol is constantly growing. Many direct targets have been identified in vitro, and protective effects have been demonstrated in various rodent models of disease.Pharmacokinetic studies have consistently shown that levels of resveratrol in serum do not reach the concentrations required for most of the reported in vitro effects, or do so only transiently. In vivo evidence has therefore become increasingly important in efforts to understand how resveratrol elicits its effects in mammals.One possibility that has been suggested based on data from lower organisms is that resveratrol acts as a caloric restriction mimetic. This hypothesis is intriguing because caloric restriction seems to slow the intrinsic rate of ageing, and improve general health, rather than block specific disease processes.The many reported in vivo effects of resveratrol are reviewed here and, whenever possible, have been related to putative mechanisms and targets. Determining the mechanism(s) by which resveratrol and similar molecules act, and developing methods to improve bioavailability and/or specificity, has enormous potential to benefit human health.

Epigenetic Regulatory Mechanisms Induced by Resveratrol

Disease-Associated Regulation of Non-Coding RNAs by Resveratrol: Molecular Insights and Therapeutic Applications

Gut Microbiota Composition in Relation to the Metabolism of Oral Administrated Resveratrol

Disease-associated regulation of gene expression by resveratrol: Special focus on the PI3K/AKT signaling pathway

Therapeutic effects of resveratrol on epigenetic mechanisms in age-related diseases: A comprehensive review

Molecular Basis of the Beneficial Actions of Resveratrol

Epigenetic regulation by quercetin: a comprehensive review focused on its biological mechanisms

Proteomics analysis of human umbilical vein endothelial cells treated with resveratrol

Anti-Inflammatory Effects of Resveratrol: Mechanistic Insights

Effect of Resveratrol on the intestinal microbiota in Type2 diabetes Mellitus mice

Health Benefits and Molecular Mechanisms of Resveratrol: A Narrative Review

Resveratrol: Multi-Targets Mechanism on Neurodegenerative Diseases Based on Network Pharmacology

Network Pharmacology, Molecular Docking, and Molecular Dynamics Study to Explore the Effect of Resveratrol on Type 2 Diabetes

Impact of Natural Compounds on DNA Methylation Levels of the Tumor Suppressor Gene RASSF1A in Cancer

Therapeutic potential of resveratrol: the in vivo evidence

Resveratrol: A Focus on Several Neurodegenerative Diseases

NMR-based metabonomic approach reveals changes in the urinary and fecal metabolome caused by resveratrol

Resveratrol-induced apoptosis is associated with activation of p53 and inhibition of protein translation in T47D human breast cancer cells

Resveratrol Modulates the Gut Microbiota and Inflammation to Protect Against Diabetic Nephropathy in Mice

Resveratrol targets G-quadruplexes to exert its pharmacological effects

Anti-Inflammatory Action and Mechanisms of Resveratrol